Related Experiment Video
Updated: Jan 26, 2026
06:34
A Component-resolved Diagnostic Approach for a Study on Grass Pollen Allergens in Chinese Southerners with Allergic Rhinitis and/or Asthma
Published on: June 4, 2017
10.4K
[Allergen-derived peptide: A promising approach in asthma]
M Klein1, A Magnan2, G Bouchaud3
1Inserm UMR 1087/CNRS UMR6291, IRS, institut du thorax, université de Nantes, 8, quai Moncousu, BP 70721, 44007 Nantes cedex 1, France.
Revue Des Maladies Respiratoires
|April 23, 2019
Summary
Hypoallergenic peptides show promise for treating allergic asthma by reducing airway hyperresponsiveness and Th2 responses. This peptide immunotherapy offers a potentially effective new approach for managing severe asthma symptoms.
Area of Science:
- Immunology
- Allergy Research
- Respiratory Medicine
Background:
- Severe asthma management often involves high-dose corticosteroids and biotherapies, impacting long-term quality of life.
- Current treatments struggle to fully control asthma symptoms and mitigate long-term effects.
Purpose of the Study:
- To investigate the potential of hypoallergenic peptides in managing allergic asthma.
- To evaluate the efficacy of peptide immunotherapy in preclinical asthma models.
Main Methods:
- Utilized mouse models of allergic asthma.
- Administered hypoallergenic peptides derived from allergens.
- Assessed airway hyperresponsiveness, Th2 immune response, and allergen-specific IgE levels.
Main Results:
- Hypoallergenic peptides demonstrated the ability to prevent airway hyperresponsiveness.
- A decrease in Th2 response and allergen-specific IgE was observed.
- Peptides showed rapid efficacy even at low allergen doses.
Conclusions:
- Peptide immunotherapy is a promising new therapeutic strategy for allergic asthma.
- Further research into the mechanisms of peptide action is warranted.
- This approach may offer an alternative to conventional high-dose therapies for severe asthma.
Related Concept Videos
01:29Asthma-I: Introduction
3.4K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.4K
02:43Peptide Bonds
82.6K
A peptide bond covalently attaches amino acids through a dehydration reaction. One amino acid's carboxyl group and another amino acid's amino group combine, releasing a water molecule. The resulting bond is the peptide bond. The products that such linkages form are peptides. As more amino acids join this growing chain, the resulting chain is a polypeptide. Each polypeptide has a free amino group at one end. This end has the N-terminal, or the amino-terminal, and the other end has a free...
82.6K
01:26Asthma-II: Pathophysiology and Classification
4.2K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.2K
01:20Asthma: Pathogenesis and Management
1.3K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.3K
01:24Asthma-III: Symptoms and Complications
3.3K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
3.3K
01:30Asthma-IV: Diagnostic and Management
3.1K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.1K